People and Partners
Pharma Futures 2 brought together pharmaceutical executives and representatives of the financial community in a Working Group. The project was run by a Secretariat, composed of the Project Director and administrative support. SustainAbility was contracted to provide research and facilitation skills.
Pension Funds
- Martin Eijgenhuijsen, ABP Investments
- Scott Streator, Ohio Public Employees Retirement System (OPERS)
- Daniel Summerfield, Universities Superannuation Scheme (USS)
The Working Group was composed of the following people, who during the time of the project were employed in the capacity outlined.
Working Group
- Stewart Adkins, Stewart Adkins Advisors Limited
- Paulo Costa, Novartis
- Lise Kingo, Novo Nordisk A/S
- Dr Niall Kirk, F&C Management
- Dr. Guy J. Lebeau, Johnson & Johnson
- Robert L. Mallett, Pfizer Inc
- John McHale, Pioneer Investment Management Ltd
- Viren Mehta, Mehta Partners
- David Y. Norton, Johnson & Johnson
- John Schaetzl, GE Asset Management
- Ian Talmage, Bayer
- Lynn A. Tetrault, AstraZeneca PLC
- Andrew Witty, GlaxoSmithKline
Project Director
- Sophia Tickell
SustainAbility Team
